The Royal College of Pediatricians issues recommendations for vaccinating against COVID-19 Add a group of children 6 months – 5 years, focusing on 8 risk groups, pointing below 2 years of age, injecting the anterior leg muscle Revealed to be injected with other vaccines on the same day.
Date 14 Sep 65 Royal College of Pediatricians of Thailand Published recommendations for vaccination against COVID-19 for children and adolescents, No. 7, dated September 12, 2022, stating that the Royal College of Pediatricians Reviewed the epidemiological, efficacy and safety data of the COVID-19 vaccine in children and adolescents. Including the information on the Covid 19 booster shot, therefore, there are new recommendations added from the 6th edition, which are:
Recommended news
5-12 years old Pfizer orange cap injection, 2 doses of 10 micrograms, should be injected spacing 3-6 months apart from moderate to severe low immunity. Another 10 mcg orange cap should be injected at least 4-8 weeks apart, for a total of 3 primary injections and another booster at least 3 months apart.
If children and adolescents change their age group during vaccination The type and dose of vaccine appropriate for age at the date of injection should be given.
Children and adolescents who have had myocardial problems or pericarditis associated with coronavirus mRNA vaccination postpone the next dose until further safety information is available. If you have been infected with coronavirus, it is recommended that primary vaccination and booster needles be vaccinated at least 3 months from the date of onset of illness. or if there are no symptoms from the date of infection
The covid vaccine can be vaccinated with other vaccines without restriction of distance. Including injections on the same day as vaccines of other ages by injecting each arm or leg If injected on the same side should be at least 1 inch apart. Ages less than 2 years are recommended for intramuscular injections in the thighs.
for COVID-19 vaccine mRNA Pfizer BioNTech Dark red cap. Children 6 months – less than 5 years old approved by the Thai FDA. It is recommended to vaccinate 3 micrograms (0.2 ml) primary vaccination 3 doses, 1 dose away from the 2 needle, 4 weeks duration (3- 8 weeks) and needle 3 away from needle 2 for a period of at least 8 weeks, which is highly recommended in high-risk children.
These include: 1. Infants less than 1 year old, including premature infants 2. Obesity (weight for height greater than +3 SD) 3. Chronic respiratory disease including asthma with moderate or severe symptoms
4. Cardiovascular disease cerebrovascular disease 5. Chronic kidney disease 6. Cancer and low immunity 7. Diabetes and 8. Genetic diseases, including Down’s syndrome. Children with severe neurological impairment children with developmental delay
Studies have shown that symptomatic COVID-19 cases can be prevented in children aged 6 months – <5 years who were not previously infected during the omicron outbreak. 73.2% and from studies Immunobridging Three doses of 3 mcg vaccination were found in children aged 6 months – < 5 years who had no evidence of infection. Immunogenicity was higher in adolescents and adults aged 16-25 who received two doses of 30 micrograms of the vaccine.